Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Amgen Inc (Symbol: AMGN), where a total of 16,898 contracts have traded so far, representing approximately 1.7 million underlying shares. That amounts to about 81.4% of A - 2025-09-19 14:45:06
Amgen Inc. (NASDAQ:AMGN – Get Free Report) has earned a consensus recommendation of “Hold” from the twenty-two brokerages that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation, seven have issued a buy recommendation and one has given a strong buy […] - 2025-09-16 03:06:59
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab US Dividend Equity ETF (Symbol: SCHD) where we have detected an approximate $245.9 million dollar inflow -- that's a 0.3% increase week over w - 2025-09-15 11:54:07
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab U.S. Large-Cap Value ETF (Symbol: SCHV) where we have detected an approximate $209.8 million dollar inflow -- that's a 1.6% increase week over - 2025-09-05 11:52:00
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro Dow30 (Symbol: UDOW) where we have detected an approximate $189.7 million dollar outflow -- that's a 20.8% decrease week over wee - 2025-08-28 11:56:19
Amgen (NASDAQ:AMGN – Get Free Report) had its price target hoisted by equities researchers at Piper Sandler from $328.00 to $342.00 in a research note issued on Monday, Marketbeat reports. The firm presently has an “overweight” rating on the medical research company’s stock. Piper Sandler’s price objective would suggest a potential upside of 18.10% from […] - 2025-08-27 02:08:56
(RTTNews) - Amgen (AMGN) announced the FDA has broadened the approved use of Repatha or evolocumab to include adults at increased risk for major adverse cardiovascular events due to uncontrolled low-density lipoprotein cholesterol. The update removes a prior requirement for a pat - 2025-08-25 10:38:20
Below is Validea's guru fundamental report for AMGEN INC (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to shareholders via - 2025-08-25 10:34:54
Below is Validea's guru fundamental report for AMGEN INC (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to shareholders via - 2025-08-18 10:40:05
The following companies are expected to report earnings after hours on 08/05/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Advanced Micro Devices, Inc. (AMD)is reporting for the quarter ending June 30, 2025. The computer company's consensus earn - 2025-08-05 15:00:01
In early trading on Tuesday, shares of Amazon.com topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.8%. Year to date, Amazon.com has lost about 1.8% of its value.
And the worst performing Dow component thus far on the day is Amg - 2025-08-05 11:21:09
Amgen Inc (Symbol: AMGN) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a strong 3.2% yield, as well as being recognized by prominent asset managers as being a socially res - 2025-08-04 10:14:41
Amgen Inc (Symbol: AMGN) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a stunning $32.91B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a strong 3.21% yield, according to the most recent Dividend Channel ''DividendRank' - 2025-08-04 10:14:38
Amgen Inc. (NASDAQ:AMGN – Get Free Report) has been given an average recommendation of “Hold” by the twenty-three brokerages that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating, eight have issued a buy rating and one has issued […] - 2025-07-30 04:58:51
Abel Hall LLC acquired a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 744 shares of the medical research company’s stock, valued at approximately $232,000. A number of […] - 2025-07-24 04:20:55
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Neos Nasdaq-100 High Income ETF (Symbol: QQQI) where we have detected an approximate $267.5 million dollar inflow -- that's a 9.4% increase week over - 2025-07-22 11:50:38
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Value ETF (Symbol: VTV) where we have detected an approximate $1.1 billion dollar inflow -- that's a 0.8% increase week over week in outstan - 2025-07-07 12:26:57
Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have received an average recommendation of “Hold” from the twenty-three analysts that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, twelve have issued a hold recommendation, eight have assigned a buy recommendation and one has issued […] - 2025-07-03 04:22:57
Allspring Global Investments Holdings LLC cut its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 4.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 69,507 shares of the medical research company’s stock after selling 3,162 shares during the period. Allspring Global Investments Holdings LLC’s holdings […] - 2025-07-02 05:42:55
Oppenheimer Asset Management Inc. acquired a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) in the 1st quarter, Holdings Channel reports. The fund acquired 886 shares of the medical research company’s stock, valued at approximately $276,000. A number of other institutional investors and hedge funds also recently added to or reduced their […] - 2025-07-01 04:52:49
Over the past year, Apple (NASDAQ: AAPL) and Amgen (NASDAQ: AMGN), two well-established companies that are part of the iconic Dow Jones Industrial Average, have faced significant headwinds. Apple is struggling due to the threat that President Donald Trump's trade agenda poses to - 2025-06-30 06:05:00
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro QQQ (Symbol: TQQQ) where we have detected an approximate $179.6 million dollar outflow -- that's a 0.7% decrease week over week ( - 2025-06-25 11:51:51
Flagship Harbor Advisors LLC boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 4.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,078 shares of the medical research company’s stock after buying an additional […] - 2025-06-25 05:26:57
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro QQQ (Symbol: TQQQ) where we have detected an approximate $549.5 million dollar outflow -- that's a 2.1% decrease week over week ( - 2025-06-17 11:50:30
Elevation Point Wealth Partners LLC lowered its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 73.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 744 shares of the medical research company’s stock after selling 2,082 shares during the […] - 2025-06-17 04:56:49
In early trading on Thursday, shares of Amgen topped the list of the day's best performing Dow Jones Industrial Average components, trading up 0.7%. Year to date, Amgen registers a 12.8% gain.
And the worst performing Dow component thus far on the day is Boeing, trading down 5 - 2025-06-12 11:49:59
Amgen Inc. (NASDAQ:AMGN – Get Free Report) SVP Rachna Khosla sold 1,500 shares of the stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $289.68, for a total value of $434,520.00. Following the completion of the transaction, the senior vice president now directly owns 8,162 shares of […] - 2025-06-09 05:30:55
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Dividend Appreciation ETF (Symbol: VIG) where we have detected an approximate $183.6 million dollar outflow -- that's a 0.2% decrease week - 2025-06-05 12:10:18
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro QQQ (Symbol: TQQQ) where we have detected an approximate $610.1 million dollar outflow -- that's a 2.4% decrease week over week ( - 2025-05-28 12:25:49
Guggenheim started coverage on shares of Amgen (NASDAQ:AMGN – Free Report) in a report released on Tuesday, Marketbeat.com reports. The firm issued a neutral rating and a $288.00 target price on the medical research company’s stock. A number of other research analysts have also commented on the company. UBS Group reissued a “neutral” rating and […] - 2025-05-23 03:06:51
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.